These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7200211)

  • 1. Skeletal muscle catabolism in amyotrophic lateral sclerosis and chronic spinal muscular atrophy.
    Corbett AJ; Griggs RC; Moxley RT
    Neurology; 1982 May; 32(5):550-2. PubMed ID: 7200211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-methylhistidine excretion in myotonic dystrophy.
    Griggs RC; Moxley RT; Forbes GB
    Neurology; 1980 Dec; 30(12):1262-7. PubMed ID: 7192806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myofibrillar protein catabolic rates in cirrhotic patients with and without muscle wasting.
    Zoli M; Marchesini G; Dondi C; Bianchi GP; Pisi E
    Clin Sci (Lond); 1982 Jun; 62(6):683-6. PubMed ID: 7083759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Methylhistidine excretion and the urinary 3-methylhistidine/creatinine ratio are poor indicators of skeletal muscle protein breakdown.
    Rennie MJ; Millward DJ
    Clin Sci (Lond); 1983 Sep; 65(3):217-25. PubMed ID: 6872456
    [No Abstract]   [Full Text] [Related]  

  • 5. [Value of the determination of urinary 3-methylhistidine (3 MEHIS) in the evaluation of postoperative muscular catabolism].
    François G; Blanc M; Blache JL; Granthil C; Rose F
    Ann Anesthesiol Fr; 1981; 22(4):339-45. PubMed ID: 6119943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased myofibrillar protein catabolism in duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
    Mussini E; Cornelio F; Colombo L; De Ponte G; Giudici G; Cotellessa L; Marcucci F
    Muscle Nerve; 1984 Jun; 7(5):388-91. PubMed ID: 6738577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Absence of effect of propranolol on urinary excretion of 3-methylhistidine in hyperthyroidism].
    Beylot M; Riou JP; Sautot G; Mornex R
    Presse Med; 1984 Sep 1-8; 13(30):1829-31. PubMed ID: 6236442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased rates of myofibrillar protein breakdown in muscle-wasting diseases.
    Warnes DM; Tomas FM; Ballard FJ
    Muscle Nerve; 1981; 4(1):62-6. PubMed ID: 7231447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative importance of non-skeletal-muscle N tau-methylhistidine and creatine in human urine.
    Afting EG; Bernhardt W; Janzen RW; Röthig HJ
    Biochem J; 1981 Nov; 200(2):449-52. PubMed ID: 7340846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excretion of total and muscular N tau-methylhistidine and creatinine in muscle diseases.
    Röthig HJ; Bernhardt W; Afting EG
    Muscle Nerve; 1984 Jun; 7(5):374-9. PubMed ID: 6738575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urinary excretion of 3-methylhistidine. Value and application to the study of protein catabolism].
    Richard JL; Rodier M; Bringer J; Cavalie G; Claustres M; Bellet H; Mirouze J
    Presse Med; 1985 Jan; 14(2):91-4. PubMed ID: 3156332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of 3-methylhistidine: an assessment of muscle protein catabolism in adult normal subjects and during malnutrition, sepsis, and skeletal trauma.
    Long CL; Birkhahn RH; Geiger JW; Betts JE; Schiller WR; Blakemore WS
    Metabolism; 1981 Aug; 30(8):765-76. PubMed ID: 6790901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased turnover of muscle contractile proteins in Duchenne muscular dystrophy as assessed by 3-methylhistidine and creatinine excretion.
    Ballard FJ; Tomas FM; Stern LM
    Clin Sci (Lond); 1979 Apr; 56(4):347-52. PubMed ID: 477220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased myofibrillar protein catabolism in Duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
    McKeran RO; Halliday D; Purkiss P
    J Neurol Neurosurg Psychiatry; 1977 Oct; 40(10):979-81. PubMed ID: 591977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle protein breakdown in thyrotoxicosis assessed by urinary 3-methylhistidine excretion.
    Yates RO; Connor H; Woods HF
    Ann Nutr Metab; 1981; 25(4):262-7. PubMed ID: 7305291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical usefulness of urinary 3-methylhistidine excretion in indicating muscle protein breakdown.
    Elia M; Carter A; Bacon S; Winearls CG; Smith R
    Br Med J (Clin Res Ed); 1981 Jan; 282(6261):351-4. PubMed ID: 6780020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Methylhistidine excretion as an index of myofibrillar protein catabolism in neuromuscular disease.
    McKeran RO; Halliday D; Purkiss P; Royston P
    J Neurol Neurosurg Psychiatry; 1979 Jun; 42(6):536-41. PubMed ID: 469561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid status and muscle protein breakdown as assessed by urinary 3-methylhistidine excretion: study in thyrotoxic patients before and after treatment.
    Rodier M; Richard JL; Bringer J; Cavalié G; Bellet H; Mirouze J
    Metabolism; 1984 Jan; 33(1):97-100. PubMed ID: 6690888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The short-term effects of protein intake on 3-methylhistidine excretion.
    Marliss EB; Wei CN; Dietrich LL
    Am J Clin Nutr; 1979 Aug; 32(8):1617-21. PubMed ID: 463800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of skeletal muscle protein in elevated rates of whole body protein catabolism in trauma patients.
    Long CL; Birkhahn RH; Geiger JW; Blakemore WS
    Am J Clin Nutr; 1981 Jun; 34(6):1087-93. PubMed ID: 7234737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.